Vectus Biosystems Ltd

NEW
ASX:VBS (Australia)  
A$ 0.20 +0.025 (+14.29%) Jul 14
At Loss
Market Cap:
A$ 12.34M ($ 8.61M)
Enterprise V:
A$ 12.47M ($ 8.70M)
Volume:
95.13K
Avg Vol (2M):
93.65K
Trade In:
Volume:
95.13K
At Loss

Business Description

Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.
Name Current Vs Industry Vs History
Cash-To-Debt
0.71
Equity-to-Asset
-1.75
Debt-to-Equity
-0.58
Debt-to-EBITDA
-0.34
Piotroski F-Score
1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
92.88
9-Day RSI
85.11
14-Day RSI
79.07
3-1 Month Momentum %
-10
6-1 Month Momentum %
3.85
12-1 Month Momentum %
264.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.58
Quick Ratio
0.58
Cash Ratio
0.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-13.7
Shareholder Yield %
-3.09

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-289.18
ROA %
-170.51
ROIC %
-403.18
3-Year ROIIC %
-33.84
ROC (Joel Greenblatt) %
-32007.69
ROCE %
-24476.47

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-8.99
EV-to-EBITDA
-9.02
EV-to-FCF
-12.06
Earnings Yield (Greenblatt) %
-11.13
FCF Yield %
-6.73

Financials

ASX:VBS's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Vectus Biosystems Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.027
Beta -0.4537
3-Year Sharpe Ratio -0.03
3-Year Sortino Ratio -0.05
Volatility % 155.61
14-Day RSI 79.07
14-Day ATR (A$) 0.010854
20-Day SMA (A$) 0.14075
12-1 Month Momentum % 264.86
52-Week Range (A$) 0.037 - 0.455
Shares Outstanding (Mil) 61.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vectus Biosystems Ltd Filings

Filing Date Document Date Form
No Filing Data

Vectus Biosystems Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Vectus Biosystems Ltd Frequently Asked Questions

What is Vectus Biosystems Ltd(ASX:VBS)'s stock price today?
The current price of ASX:VBS is A$0.20. The 52 week high of ASX:VBS is A$0.46 and 52 week low is A$0.04.
When is next earnings date of Vectus Biosystems Ltd(ASX:VBS)?
The next earnings date of Vectus Biosystems Ltd(ASX:VBS) is .
Does Vectus Biosystems Ltd(ASX:VBS) pay dividends? If so, how much?
Vectus Biosystems Ltd(ASX:VBS) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Vectus Biosystems Ltd

No articles.